FNDC5 and metabolic syndrome: In addition, Park et al. [11] also concluded that irisin is associated with increased odds of having metabolic syndrome and insulin resistance, suggesting physiological compensatory mechanism that would result in increased irisin levels in metabolic diseases due to an underlying decreased sensitivity to irisin’s effects.